Total synthesis of syringolin A

Organic Letters

Volumn 12, Issue 15, 2010, Pages 3453-3455

  Dai, Chunhui ^a   Stephenson, Corey R J ^a  

^a Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; CYCLOPEPTIDE; SYRINGOLIN A; VALINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; PSEUDOMONAS SYRINGAE; STEREOISOMERISM; SYNTHESIS;

ALDEHYDES; CYCLIZATION; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC; PSEUDOMONAS SYRINGAE; STEREOISOMERISM; VALINE;

EID: 77955136605     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol101252y     Document Type: Article

References (34)

1. Wäspi, U.; Blanc, D.; Winkler, T.; Ruedi, P.; Dudler, R. Mol. Plant-Microbe Interact. 1998, 11, 727
2. Wäspi, U.; Hassa, P.; Staempfli, A. A.; Molleyres, L. P.; Winker, T.; Dudler, R. Microbiol. Res. 1999, 154, 89
3. Wäspi, U.; Schweizer, P.; Dudler, R. Plant Cell 2001, 13, 153
4. Coleman, C. S.; Rocetes, J. P.; Park, D. J.; Wallick, C. J.; Warn-Cramer, B. J.; Michel, K.; Dudler, R.; Bachmann, A. S. Cell Proliferation 2006, 39, 599
5. Groll, M.; Schellenberg, B.; Bachmann, A. S.; Archer, C. R.; Huber, R.; Powell, T. K.; Lindow, S.; Kaiser, M.; Dudler, R. Nature 2008, 452, 755
6. Ciechanover, A. Angew. Chem., Int. Ed. 2005, 44, 5944
7. Goldberg, A. L. Biochem. Soc. Trans. 2007, 35, 12
8. For a discussion of the proteasome as a target for cancer chemotherapy, see
9. Almond, J. B.; Cohen, G. M. Leukemia 2002, 16, 433
10. Adams, J. Cancer Cell 2004, 5, 417
11. Kyle, R. A.; Rajkumar, S. V. N. Engl. J. Med. 2004, 351, 1860
12. Rajkumar, S. V.; Richardson, P. G.; Hideshima, T.; Anderson, K. C. J. Clin. Oncol. 2005, 23, 630
13. Borissenko, L.; Groll, M. Chem. Rev. 2007, 107, 687
14. Chauhan, D.; Hideshima, T.; Anderson, K. C. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 465
15. Clerc, J.; Groll, M.; Illich, D. J.; Bachmann, A. S.; Huber, R.; Schellenberg, B.; Dudler, R.; Kaiser, M. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 6507
16. Clerc, J.; Schellenberg, B.; Groll, M.; Bachmann, A. S.; Huber, R.; Dudler, R.; Kaiser, M. Eur. J. Org. Chem. 2010, published online May 19, 2010; DOI: 10.1002/ejoc.201000317.
17. Pirrung, M. C.; Biswas, G.; Ibarra-Rivera, T. R. Org. Lett. 2010, 12, 2402
18. Garner, P.; Park, J. M. J. Org. Chem. 1987, 52, 2361
19. Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815
20. The stereochemical integrity of the α-stereogenic center and % ee of 7 were determined by HPLC analysis.
21. For seminal studies on the preparation and utility of vinylogous amino acids, see: Hagihara, M.; Anthony, N. J.; Stout, T. J.; Clardy, J.; Schreiber, S. L. J. Am. Chem. Soc. 1992, 114, 6568
22. Hagihara, M.; Schreiber, S. L. J. Am. Chem. Soc. 1992, 114, 6570
23. During the preparation of this manuscript, Kaiser and coworkers described a similar approach to fragment 4; see ref 9b.
24. 1H NMR.
25. Decomposition and epimerization were always observed when handling the aldehyde. In contrast, the carboxylic acid was found to be quite stable and did not undergo noticeable epimerization.
26. For an example of the lability of the products of oxidation of vinylglycinol derivatives, see
27. Campbell, A. D.; Taylor, R. J. K.; Raynham, T. M. Chem. Commum. 1999, 24, 245
28. 1H NMR as compared with the coupling of 4 with (±)-α- methylbenzylamine. See Supporting Information for further details.
29. This intermediate was also prepared in the recently reported synthesis by Pirrung and coworkers using a Horner-Wadsworth-Emmons macrocyclization. See ref 10 for details.
30. Analysis of the crude UPLC-MS data indicated that dimeric and trimeric products are also formed during the formation of the strained 12-membered macrocycle.
31. The isocyanate was prepared using triphosgene; see
32. Sunder-Plassmann, N.; Sarli, V.; Gartner, M.; Utz, M.; Seiler, J.; Huemmer, S.; Mayer, T. U.; Surrey, T.; Giannis, A. Biorg. Med. Chem. 2005, 13, 6094
33. Majer, P.; Randad, R. S. J. Org. Chem. 1994, 59, 1937
34. + 494.2979, found 494.3003.